Diabetic Retinopathy Therapy
Mostrando 1-12 de 16 artigos, teses e dissertações.
-
1. Effects of triamcinolone acetonide associated with panretinal photocoagulation in proliferative diabetic retinopahty / Efeitos do acetonido de triancinolona associado à panfotocoagulação na retinopatia diabética proliferativa
INTRODUCTION: The gold standard treatment for proliferative diabetic retinopahty (PDR) with and without clinically significant macular edema (CSME), as stablished by the Early Treatment Diabetic Retinopathy Study (ETDRS), is panretinal photocoagulation (PRP). This treatment lowers the rate of severe vision loss, but does not increase vision. The aim of this
Publicado em: 2008
-
2. Use of intravitreal triamcinolone and laser photocoagulation for the treatment of diffuse diabetic macular edema / Tratamento do edema macular difuso do diabético com triancinolona intravítrea e fotocoagulação com laser de argônio
INTRODUCTION: The diffuse macular edema is an important cause of visual impairment in diabetic subjects. Laser photocoagulation is the main treatment for this disorder, however, it is not effective in a large number of patients. In this study, we evaluated the efficacy of intravitreal use of triamcinolone acetonide combined with laser photocoagulation for th
Publicado em: 2008
-
3. A associação entre o perfil clínico e psicossocial de pessoas com diabetes mellitus usuárias de uma unidade de saúde da família de Sorocaba - SP / The connection between the clinical and psychosocial profile of diabetes mellitus in a health family unit users Sorocaba - SP
Diabetes Mellitus (DM) is a chronic disease responsible for the high unhealthy and mortality indicators. Although several attempts of interventions have been done to control the disease and take in the chronic disorder incidence, the issues are very fearful. The primary attention of health is essential for diabetic´s accompaniment (DM), especially on The Fa
Publicado em: 2007
-
4. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa.
A total of 43 patients (86 eyes) with chronic viral hepatitis were examined prospectively before and after the start of interferon therapy. Of 37 non-diabetic patients, 23 (group A1) did not have retinopathy or subconjunctival haemorrhage, 11 (group A2) developed retinopathy, and three (group A3) exhibited subconjunctival haemorrhage during the treatment. In
-
5. Synergism between diabetic and radiation retinopathy: case report and review.
It is suspected that radiation retinopathy is more likely to develop in an eye with preexisting diabetic retinopathy than in a normal eye. However, there is only one report of this occurring, at a radiation dose of 4500 rads. We present a woman with minimal diabetic retinopathy who had breast carcinoma which was treated with chemotherapy but metastasised to
-
6. Antisense Oligonucleotide Therapy in Diabetic Retinopathy
Diabetic retinopathy is one of the leading causes of blindness in the United States and other parts of the world. Historically, laser photocoagulation and vitrectomy surgery have been used for the treatment of diabetic retinopathy, including diabetic macular edema. Both procedures have proven to be useful under certain conditions but have their limitations.
Diabetes Technology Society.
-
7. Optic disc neovascularisation in diabetic retinopathy: I. A system for grading proliferation at the optic nerve head in patients with proliferative diabetic retinopathy.
An anatomical taxonomy for neovascular proliferation of the optic nerve head in patients with proliferative diabetic retinopathy is presented. The technique consists in comparing (A) number of involved quadrants, (B) calibre of vessels, (C) neovascular density, (D) neovascular area, (E) plane of proliferation, and (F) fluorescein angiographic findings. A sim
-
8. Colour vision of diabetics.
The Farnsworth-Munsell 100-hue test has been assessed as a screening test for the detection of diabetic retinopathy likely to benefit from laser photocoagulation therapy. Two hundred and thirty-two diabetic eyes of 126 patients were tested. The results were assessed both for total error score relative to age and for the presence of polarity. Although the inc
-
9. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGF
Acute intensive insulin therapy is an independent risk factor for diabetic retinopathy. Here we demonstrate that acute intensive insulin therapy markedly increases VEGF mRNA and protein levels in the retinae of diabetic rats. Retinal nuclear extracts from insulin-treated rats contain higher hypoxia-inducible factor-1α (HIF-1α) levels and demonstrate increa
American Society for Clinical Investigation.
-
10. Radiation retinopathy.
Radiation therapy is effective against many cancerous and noncancerous disease processes. As with other therapeutics, side effects must be anticipated, recognized, and managed appropriately. Radiation retinopathy is a vision-threatening complication of ocular, orbital, periorbital, facial, nasopharyngeal, and cranial irradiation. Factors that appear importan
-
11. Avascular necrosis of bone complicating corticosteroid replacement therapy.
Two patients who developed widespread severe avascular necrosis of bone while on steroid replacement therapy are described. One, a diabetic, underwent yttrium-90 pituitary ablation for retinopathy and developed avascular necrosis within 18 months of starting prednisolone. The other, who had Addison's disease, developed avascular necrosis within 14 months of
-
12. Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications.
Limited joint mobility (LJM) of the hand was studied by visual examination in 361 diabetic outpatients aged 11 to 83 years, and 45 non-diabetic controls, without evidence of arthritis. LJM was evident in 58% of diabetic subjects and 4% of controls (p less than 0.001). LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (ID